The University of Texas Health Science Center at San Antonio broke ground and unveiled the cornerstone for the UT Health San Antonio Multispecialty and Research Hospital, a destination center for research and treatment of cancer and other complex diseases that disproportionately impact the people of South Texas.
The Mary Kay Foundation on Oct. 22 announced that UT Health San Antonio is among its 2020 cancer grant recipients. The grants are awarded annually to top accredited research institutions in the United States conducting innovative translational research to better understand cancers that affect women.
In patients with high-grade cancer in the lining of the bladder, cancer often comes back within a year following standard treatment.
Although there are several approved treatments, none have significantly improved survival with few side effects. However, a new study evaluating a novel immunotherapy called nadofaragene firadenovec (NF) gene therapy may offer new hope.
UT Health San Antonio and its Mays Cancer Center will receive a $6 million award from the Cancer Prevention and Research Institute of Texas (CPRIT) to recruit Alexander Mazin, PhD, a senior, highly accomplished biochemist and cancer biologist currently at Drexel University College of Medicine.